MDBPF Stock Chart & Stats
$2.78
$0.00(0.00%)
At close: 4:00 PM EDT
$2.78
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$2.78 - $3.90
Previous CloseN/A
Volume48.05K
Average Volume (3M)0.00
Market Cap
$9.93B
Enterprise Value$13.46K
Total Cash (Recent Filing)$453.30M
Total Debt (Recent Filing)$481.30M
Price to Earnings (P/E)30.4
Beta0.54
Next Earnings
Aug 20, 2026EPS Estimate
0.08Next Dividend Ex-DateN/A
Dividend Yield3.26%
Share Statistics
EPS (TTM)0.17
Shares Outstanding2,754,003,200
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)5.95
Price to Sales (P/S)1.63
P/FCF Ratio37.62
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$3.49Price Target Upside25.45% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)0.18
Revenue Forecast (FY)$6.79B
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet & Strong ROEVery low leverage and consistently high returns on equity provide durable financial flexibility. This supports dividend policy, gives capacity to raise Tier‑2 debt or fund M&A, and cushions underwriting volatility, enhancing long‑term solvency and strategic optionality.
Medibank Health Accelerated GrowthSustained double‑digit growth and improving margins in Medibank Health diversify revenue away from pure underwriting. This builds a higher‑margin services franchise, supports cross‑sell into insured members, and creates a structural earnings stream less sensitive to claims cycles.
Policyholder Growth And EngagementPositive net membership growth and rising acquisition imply stronger distribution and brand competitiveness. High engagement rates and delivered out‑of‑pocket savings increase retention and cross‑sell potential, supporting premium base stability and long‑term underwriting scale benefits.
Bears Say
Volatile Cash GenerationLarge year‑to‑year swings in free cash flow reduce predictability for dividends, debt servicing and M&A funding. Persistent volatility undermines confidence in cash conversion and may force higher capital buffers or constrain reinvestment during adverse cycles.
Revenue Mix Shifting To Lower-tier ProductsA structural shift toward lower‑tier policies compresses revenue per policy and can reduce underwriting margins over time. If sustained, it limits premium pricing power, increases sensitivity to cost inflation, and forces more reliance on scale or non‑insurance services to preserve profits.
Claims Inflation And Utilization DynamicsRising extras claims and declining hospital utilization create unpredictability in claims cost trends and revenue mix. Ongoing healthcare inflation and utilization normalization could keep pressure on margins and require sustained pricing or provider negotiation, challenging long‑term underwriting stability.
Medibank Private News
MDBPF FAQ
What was Medibank Private Ltd.’s price range in the past 12 months?
Medibank Private Ltd. lowest stock price was $2.78 and its highest was $3.90 in the past 12 months.
What is Medibank Private Ltd.’s market cap?
Medibank Private Ltd.’s market cap is $9.93B.
When is Medibank Private Ltd.’s upcoming earnings report date?
Medibank Private Ltd.’s upcoming earnings report date is Aug 20, 2026 which is in 27 days.
How were Medibank Private Ltd.’s earnings last quarter?
Medibank Private Ltd. released its earnings results on Feb 18, 2026. The company reported $0.076 earnings per share for the quarter, missing the consensus estimate of $0.077 by -$0.001.
Is Medibank Private Ltd. overvalued?
According to Wall Street analysts Medibank Private Ltd.’s price is currently Undervalued.
Does Medibank Private Ltd. pay dividends?
Medibank Private Ltd. pays a Notavailable dividend of $0.059 which represents an annual dividend yield of 3.26%. See more information on Medibank Private Ltd. dividends here
What is Medibank Private Ltd.’s EPS estimate?
Medibank Private Ltd.’s EPS estimate is 0.08.
How many shares outstanding does Medibank Private Ltd. have?
Medibank Private Ltd. has 2,754,003,200 shares outstanding.
What happened to Medibank Private Ltd.’s price movement after its last earnings report?
Medibank Private Ltd. reported an EPS of $0.076 in its last earnings report, missing expectations of $0.077. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Medibank Private Ltd.?
Currently, no hedge funds are holding shares in MDBPF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medibank Private Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$3.49 (25.45% Upside)
$3.49 (25.45% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
66.92%
12-Months-Change
Fundamentals
Return on Equity
3.26%
Trailing 12-Months
Asset Growth
9.08%
Trailing 12-Months
Company Description
Medibank Private Ltd.
Medibank Private Limited (MPL.AX) is an Australian firm offering private health insurance alongside a variety of health services. The company operates through two primary divisions. Its Health Insurance division provides a comprehensive suite of private health insurance policies, encompassing coverage for hospital treatments and supplementary benefits for services like dental, optical, and physiotherapy. This division also caters to international visitors and students with specific insurance products, all underwritten by the Medibank and ahm brands. The Medibank Health division delivers health management programs, in-home care solutions, and telehealth services, primarily serving governmental and corporate clients. Furthermore, this segment handles the distribution of travel, life, and pet insurance products. Established in 1976, Medibank Private Limited is headquartered in Docklands, Australia.
MDBPF Stock 12 Month Forecast
Average Price Target
$3.49
▲(25.45% Upside)
Technical Analysis
Ownership Overview
0.09% Insiders
6.61% Mutual Funds
<0.01% Other Institutional Investors
82.58% Public Companies and
Individual Investors